Structural basis of DNA methylation-dependent site selectivity of the Epstein–Barr virus lytic switch protein ZEBRA/Zta/BZLF1. Issue 1 (10th December 2021)

• Record Type: Journal Article
• Authors: Bernaudat, Florent; Gustems, Montse; Günther, Johannes; Oliva, Mizar F; Buschle, Alexander; Göbel, Christine; Pagniez, Priscilla; Lupo, Julien; Signor, Luca; Müller, Christoph W; Morand, Patrice; Sattler, Michael; Hammerschmidt, Wolfgang; Petosa, Carlo
• Is Part Of: Nucleic acids research. Volume 50:Issue 1(2022)
• Page Start: 490
• Page End: 511
• Publication Date: 2021-12-10
• Subjects: Nucleic acids -- Periodicals; Molecular biology -- Periodicals; 572.805
• DOI: 10.1093/nar/gkab1183
• Languages: English
• ISSNs: 0305-1048

Abstract

Abstract: In infected cells, Epstein–Barr virus (EBV) alternates between latency and lytic replication. The viral bZIP transcription factor ZEBRA (Zta, BZLF1) regulates this cycle by binding to two classes of ZEBRA response elements (ZREs): CpG-free motifs resembling the consensus AP-1 site recognized by cellular bZIP proteins and CpG-containing motifs that are selectively bound by ZEBRA upon cytosine methylation. We report structural and mutational analysis of ZEBRA bound to a CpG-methylated ZRE (meZRE) from a viral lytic promoter. ZEBRA recognizes the CpG methylation marks through a ZEBRA-specific serine and a methylcytosine-arginine-guanine triad resembling that found in canonical methyl-CpG binding proteins. ZEBRA preferentially binds the meZRE over the AP-1 site but mutating the ZEBRA-specific serine to alanine inverts this selectivity and abrogates viral replication. Our findings elucidate a DNA methylation-dependent switch in ZEBRA's transactivation function that enables ZEBRA to bind AP-1 sites and promote viral latency early during infection and subsequently, under appropriate conditions, to trigger EBV lytic replication by binding meZREs.